Skip to content
IFPMA Twitter
IFPMA LinkedIn
IFPMA Youtube
IFPMA Slideshare
IFPMA Flickr
IFPMA RSS
Search for:
Primary Menu
Who We Are
IFPMA in Brief
Our Governance and Leadership
Our Membership
Full Members
Associations
Companies
Affiliate Members
Our Experts
Join Us
Topics
News Center
News Releases
Blog
Global Health Matters
Science Matters
DG’s Column
Statements
Resources
Publications
News Releases
Statements
Position Papers
Publications
External Studies
Infographics
Event Highlights
Multimedia
Interviews
Videos
Slides
IFPMA Interactive Platforms
IFPMA COVID-19 Hub
Global Health Progress
50 Years of Global Health Progress
Events
Upcoming IFPMA Events
Geneva Pharma Forums
Assemblies
Other IFPMA Events
IFPMA in External Events
IFPMA Press Briefings
Past IFPMA Events
Geneva Pharma Forums
Assemblies
Other IFPMA Events
IFPMA in External Events
IFPMA Press Briefings
Partners
BCR
Inventing Medicines and Vaccines
Strengthening Regulatory Systems
Ethics and Business Integrity
Boosting Innovation and Access
Tackling Global health challenges
Climate change
Economic footprint
IP
Sustainable innovation
Value of innovation
spotlight
Value of innovation
African Medicines Agency
Biosimilars
Biotherapeutic medicines
Falsified medicines
Import testing
Pharmacovigilance
Quality, safety, and efficacy
Regulatory conferences
Regulatory system strengthening / Harmonization
Supply chain
The Africa Regulatory Network (ARN)
The ARN: Le réseau africain de réglementation pharmaceutique
spotlight
Pharmacovigilance
IFPMA Code of Practice (2019)
Our Ethos in Action
Our Ethos
Code eLearning Tool
IFPMA Notes for Guidance
IFPMA Complaint Operating Procedure
How to File a Code Complaint
Complaint Submission Form
Cases
Business Ethics for APEC SMEs Initiative
Consensus Framework for Ethical Collaboration
spotlight
IFPMA Code of Practice (2019)
Access to medicines
Global Policy Principles on Digital Health
Health technology assessment
IP
Technology Transfer
Trade
spotlight
Access to medicines
Ageing
Antimicrobial resistance
Cancer
Child and maternal health
COVID-19
Diabetes
Ebola
Falsified medicines
HIV/AIDS
Influenza
Malaria
Mental and neurological disorders
Neglected tropical diseases
Non-communicable diseases
Pandemic Preparedness
Public health implications of the implementation of the Nagoya Protocol
Rare diseases
Supply chain
Sustainable development goals
Tuberculosis
Universal Health Coverage
Vaccination confidence
Vaccines innovation
Vaccines protect communities
Vaccines sustainability
Value of immunization
Viral hepatitis
spotlight
Universal Health Coverage
Home
>
Tag: News Releases
Tag: News Releases
IFPMA launches new policy principles and report on Rare Disease Day 2017 to benefit patients, healthcare and society
Thomas Cueni takes helm of IFPMA as Director General
IFPMA and the IAEA through its Programme of Action for Cancer Therapy (PACT) join forces to make a difference in comprehensive cancer control
Global Biopharmaceutical Industry Takes Action to Combat Antimicrobial Resistance (AMR)
Leading Pharmaceutical Companies Present Industry Roadmap to Combat Antimicrobial Resistance
World cancer day: R&D pharmaceutical industry partnerships to enhance access to cancer care
Partnership to improve prevention of women’s cancers and quality of cancer registries in LAC reaches 1 year milestone
Global pharmaceutical associations welcome MEDICRIME convention, landmark tool to curb global medicines counterfeiting
IFPMA welcomes seven new members
Release on the Lancet commission on health and climate change report
WHA 68, Item 17.3, Substandard/spurious/falsely-labelled/falsified/counterfeit medical products
Research-based pharmaceutical companies are contributing to emergency aid efforts for Nepal
Pour une approche intégrée contre les faux médicaments
New research-based pharmaceutical industry report provides insights on how to slow down antimicrobial resistance (AMR) and boost antibiotic R&D
L’Afrique a besoin de systèmes réglementaires plus efficaces afin d’améliorer l’accès aux médicaments
IFPMA pharma’s commitment to global vaccine action plan and to ‘closing the immunization gap’
New study reveals how the essential medicines list operates
Publication Launch - New study to change how people perceive pharma: from cost driver to economy booster
Open letter to G7 Heads of State on neglected tropical diseases
Pharmaceutical industry makes progress in cutting-edge R&D for neglected diseases
WADA: Second international pharmaceutical conference addresses doping in sport
Stefan Oschmann elected new President of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
PPP launched to improve prevention of women’s cancers and quality of cancer registries in Latin America and the Caribbean
IFPMA supports world hepatitis day 2014
Malaysian airlines 17: IFPMA offers condolences and extends profound sympathy to HIV community
Fight the fakes campaign gains momentum as eleven new partners join global movement
Stop “Silent epidemic”: Research-based pharmaceutical industry report supports comprehensive approach to viral hepatitis
'4 Healthy Habits': mobilizing volunteers to help fight noncommunicable diseases
The World Health Assembly resolution on psoriasis represents a milestone for campaigners.
Partnership in Fighting Non-Communicable Diseases
1
2
3
Next »
Other Tags
Access
Access to antiretrovirals
Access to Medicines
Access to vaccines
Africa
AMR
AMR Industry Alliance
Anti-Counterfeit
Antibiotics
antimicrobial resistance
antivirals
Biosimilars
Biotherapeutic Medicines
Biotherapeutics
Cancer
Clinical Trials
Code of Practice
collaboration
Counterfeit Medicines
Counterfeits
COVID-19
COVID-19 vaccines
Dementia
Developing World
Diabetes
Economic footprint
Epidemics
Ethics
Event Highlights
Fake Medicines
Fakes
Falsified Medicines
Fight the Fakes
Flu
Global Health
global health security
harmonization
Health
Health Partnerships
HIV/AIDS
IFPMA
IFPMA Assembly
IFPMA Statement
Immunization
Incremental Innovation
Influenza
Infographic
Infographics
Innovation
Innovation ecosystem
Intellectual Property
IP
Malaria
MDGs
Medicines
Mental and Neurological Disorders
NCDs
Neglected Tropical Diseases
News Releases
Non-Communicable Diseases
Novel Coronavirus (COVID-19)
NTDs
pandemic
Pandemic Influenza
Pandemic preparedness
pandemics
partnership
Partnerships
Pharma
Pharmacovigilance
Position Paper
Prevention
Publications
Public Health
Quality
R&D
Regulatory
regulatory systems
Related Links
Research
Safety
SDGs
Seasonal Influenza
Statements
Supply chain
Sustainable Development Goals
Sustainable Innovation
trade
Treatments
Tuberculosis
UHC
Universal Health Coverage
Vaccine
Vaccines
Value of Innovation
Videos
WHA
WHO
WIPO
Women’s Cancers